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Un estudio comparativo de Ketofol y sodio tiopental en pacientes sometidos a dilatación y curetaje por anestesia general
onsidering that the combined drug, Keto-
fol has been used and its efficacy observed 
in patients, we have aimed to compare the 
effects of ketofol and thiopental sodium on patients who 
are undergoing dilatation and curettage. This study was 
conducted as a randomized controlled clinical trial. In this 
study, 150 patients undergoing dilatation and curettage 
after classification were randomly selected and enrolled. 
The first group received ketofol, while thiopental sodium 
was administered to the second group. Any change in he-
modynamics or respiratory distress, including the occur-
rence of apnea or hypotension, desaturation and the need 
for respiratory support were recorded in both groups. Fi-
nally, after the completion of the surgery and transfer to 
the recovery room, the recovery rate of each group was 
recorded, and once they were conscious and alert, were 
questioned about their satisfaction. All of the patient in-
formation was entered into the SPSS v18 software, and 
the data were analyzed. This study was conducted on 150 
patients undergoing curettage; the mean ages in the first 
and second groups were 31.82 ± 9.18 and 33.64 ± 11.39 
years, respectively. Ninety two percent of patients in the 
ketofol group and 100% of the patients in the thiopental 
sodium group experienced apnea and needed respiratory 
support. About 25.3% of patients in the ketofol group 
and 44% of patients in the thiopental group required a 
re-dose of the drug for the anesthetic process. The dura-
tion of recovery in the ketofol group was lower than the 
other group. About 2.7% of the patients in the ketofol 
group and 12% of the patients in the thiopental group 
had hallucinations and delusions at the end of the opera-
tion Six patients in the thiopental group also had hiccups. 
The results of the present study showed that ketofol is a 
better drug than thiopental because of the duration of an-
esthesia, reducing the need for medication, the incidence 
of apnea, and the complications of anesthesia
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eniendo en cuenta que el fármaco combinado, 
Ketofol se ha utilizado y su eficacia se ha obser-
vado en pacientes, el objetivo fue comparar los 
efectos del ketofol y el sodio tiopental en pacientes que es-
tán en proceso de dilatación y legrado. Este estudio se reali-
zó como un ensayo clínico aleatorizado controlado. En este 
estudio, 150 pacientes sometidos a dilatación y legrado 
después de la clasificación fueron seleccionados al azar y se 
inscribieron. El primer grupo recibió ketofol, mientras que 
el tiopental sódico se administró al segundo grupo. Cual-
quier cambio en la hemodinámica o dificultad respiratoria, 
incluida la aparición de apnea o hipotensión, la desatura-
ción y la necesidad de asistencia respiratoria se registraron 
en ambos grupos. Finalmente, después de la finalización 
de la cirugía y el traslado a la sala de recuperación, se regis-
tró la tasa de recuperación de cada grupo, y una vez que 
estuvieron conscientes y alertas, se les preguntó acerca de 
su satisfacción. Toda la información del paciente se ingresó 
en el software SPSS v18 y los datos se analizaron. Este es-
tudio se realizó en 150 pacientes sometidos a curetaje; Las 
edades medias en el primer y segundo grupo fueron 31.82 
± 9.18 y 33.64 ± 11.39 años, respectivamente. Noventa 
y dos por ciento de los pacientes en el grupo de ketofol y 
el 100% de los pacientes en el grupo de sodio tiopental 
experimentaron apnea y necesitaron asistencia respiratoria. 
Alrededor del 25,3% de los pacientes en el grupo de keto-
fol y el 44% de los pacientes en el grupo de tiopental requi-
rieron una nueva dosis del fármaco para el proceso anesté-
sico. La duración de la recuperación en el grupo de ketofol 
fue menor que en el otro grupo. Alrededor del 2,7% de los 
pacientes en el grupo de ketofol y el 12% de los pacientes 
en el grupo de tiopental tuvieron alucinaciones y delirios al 
final de la operación Seis pacientes en el grupo de tiopental 
también tuvieron hipo. Los resultados del presente estudio 
mostraron que el ketofol es un fármaco mejor que el tio-
pental debido a la duración de la anestesia, lo que reduce 
la necesidad de medicación, la incidencia de apnea y las 
complicaciones de la anestesia.














bout 211 million pregnancies occur 
annually all over the world, of which, 
46 million lead to abortion1. Common 
abortion therapies include pharmaceutical and mechani-
cal therapies.
Dilatation and curettage (D & C) is one of the mechanical 
methods used for abortion. In this operation, opening the 
cervix or dilatation is far more painful than curettage2.The 
anesthetic method for this operation can be general (GA) 
or regional, GA is the most common anesthetic approach 
based on the surgeon and patients’ wish. Because bleed-
ing is common in this operation, maintaining the hemody-
namic during anesthesia is very important. The duration of 
the stay in the hospital is often short, and the patient can 
be discharged if they do not develop any complications3. 
So, it’s best to use a method to get the patient to wake 
up and recover faster. Therefore, the choice type of drug 
in the general anesthesia should be carefully investigated 
and the best medicine be chosen4. Thiopental induces an-
esthesia by bonding to the position of ionophore chloride 
in the Gaba aminobutiric acid receptor (GABA) and inhib-
iting this receptor about 30 seconds after injection. It has 
no analgesic effect, but its effect on the cardiovascular 
system and the reduction of vascular resistance leads to 
hypotension and sometimes, reflex tachycardia5. Propo-
fol is a drug with rapid onset and hepatic clearance after 
intravenous administration. It has direct antinociceptive 
effects but no analgesic effect. On the other hand, Ket-
amine acts on the NMDA via antagonistic effects, which 
increases the systolic blood pressure (SBP), diastolic blood 
pressure (DBP), and heart rate (HR). Ketamine has dose-
dependent effects of inaccuracy and analgesia6. Ketofol is 
a combination of two drugs (propofol and ketamine) and 
is used in anesthesia.
Considering that ketofol and its efficacy has been ob-
served among patients, we have aimed to compare the 
effects of ketofol and thiopental sodium on the patients 
undergoing dilation and curettage.
his study was approved by ethical committee of 
Ardabil University of medical sciences (1395.88) 
and written informed consent was obtained 
from all subjects, a legal surrogate, or the requirement 
for written informed consent was waived by ethical com-
mittee. The clinical trial with the IRCT2017031923559N9 
code (Somaiyeh Matin, 2017.4.24) was registered before 
patient enrollment authors. This randomized controlled 
clinical trial was conducted before on patients with missed 
or incomplete abortion undergoing dilatation and curet-
tage. In this study, 150 patients aged over 16 years and 
candidates for dilation and curettage with ASA class 1 
and 2 were enrolled after obtaining informed consent. Pa-
tients with a history of susceptibility to propofol and oth-
er intravenous anesthetic drugs, patients with substance 
abuse, alcohol and psychotropic drugs, as well as patients 
with gastrointestinal ulcers, kidney disease or hyperten-
sion, and hypertension, osteopenia and osteoporosis, and 
uncontrolled hypertension were excluded. The patients 
were randomly classified into two groups and placed in 
two blocks.
A and B. Group A or Group 1 were the ketofol group and 
group B or Group 2 were the thiopental sodium group. 
The preparation of the drugs was carried out by the anes-
thesia nurses, and after delivery of the syringes, they were 
covered with a white label. The drugs were administered 
by an anesthesiologist who did not know the drug con-
tent. In both groups, the patients in the operating room 
underwent cardiopulmonary monitoring. Then, the ap-
propriate intravenous route was established, and the pa-
tients were hydrated, and received oxygen by facemask. 
Midazolam 0.05 mg / kg, fentanyl 1 µg / kg, and lidocaine 
1 mg / kg for each patient were administered.
Subsequently, the first group received ketofol (which was 
mixed with 2: 1 propofol and ketamine in a syringe), and 
the second group received thiopental sodium 3 mg / kg 
body weight. The medication injection rate was 10 mg / 
sec. Any change in the hemodynamics or respiratory dis-
tress including the occurrence of apnea or hypotension, 
desaturation and the need for respiratory support were 
recorded in both groups. Eventually, after completion of 
surgery and transfer to the recovery room, the patients 
were questioned about satisfaction and anesthesia. All 
patient information was completed by the anesthesiolo-
gist. Finally, all the data was entered into the SPSS v18 sta-
tistical program and the data was analyzed. In this study, 
the t-test and chi-square test were used and P value less 
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n this study, 150 patients were evaluated in two 
groups (the first group receiving the ketofol and the 
second group receiving the thiopental sodium). The 
mean age of the patients in the first group was 31.82 ± 
9.18 years and in the second group was 33.64 ± 11.36 
years (P = 0.258).
The incidence of apnea and the need for respiratory sup-
port in the thiopental sodium group were higher than the 
ketofol group (Table 1). Also, the mean duration of apnea in 
the first and second groups were 50.75 ± 27.77 and 99.22 
± 58.17 seconds, respectively (P <0.001). After recording the 
systolic, diastolic blood pressure and heart rate before and af-
ter induction did not show significant differences in the two 
groups (Table 2), but in each group, there were significant 
differences in the vital signs (Table 3). In this study, no cases 
of hypotension and bradycardia were reported. Awakening 
during anesthesia showed no significant difference in the 
two groups, but the amount of drug re-administration dur-
ing anesthesia was significantly lower in the ketofol group 
than in the other group (P = 0.016) (Table 1). The mean arrival 
time of the Aldrete score was 9 and recovery in the ketofol, 
and thiopental sodium groups were 13.21 ± 3.13 and 19.12 
± 21.5 minutes, respectively (P <0.001). Drug complications 
in Group A were higher than Group B, but the satisfaction 
of patient and surgeon for the anesthetic level did not show 






Table 1. Different variables in both groups before and after induction
Table 2. Signs of vital signs in both groups before and after induction
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Various studies have demonstrated that 
the effect of the combination of propo-
fol and ketamine for the induction of 
anesthesia is different when injected by a syringe due to 
different kinetic effects on each other, and the combined 
drug (Ketofol) produces more effective sedative effects7. 
In the study by Sawas et al., 52% of the recipients of ke-
tofol and 73% of the propofol recipients experienced re-
spiratory supplements (P = 0.035) 8. In a study by Goh et 
al., the incidence of apnea in propofol (3.3%) was lower 
than ketofol, and in ketofol (6.3%) was less than fen-
tanyl + propofol (23.1%)9. Frey et al. reported respiratory 
suppression in propofol recipients more than cofactor re-
cipients10. Jalili, in his meta-analysis study also stated that 
ketofol can significantly reduce respiratory complications, 
including depression of the respiratory system11. However, 
in the study by David and colleagues, there was no signifi-
cant difference in the incidence of apnea in propofol and 
ketofol12. In this study, it was found that the incidence of 
apnea and the need for respiratory support in the thio-
pental sodium recipients was higher than that of ketofol. 
Its incidence in this study was more than other studies, 
which is probably due to the definition of apnea (respira-
tory discontinuation of 10 seconds) in this study and its 
difference with other studies. In their study, Ustun et al. 
studied the effects of ketofol (0.5 mg/kg) and thiopental 
(3 mg / kg) on MRI candidates; they observed that the 
heart rate decreased in both groups. However, there was 
no significant difference between the two groups in rela-
tion to each other13. Gholipour et al. also stated that keto-
fol produces a more stable hemodynamic than the other 
two groups (etomidated, thiopental + ketamine)14. Also, 
Garg et al. reported the ketamine and propofol combina-
tion as the best combination for the hemodynamic stabil-
ity of patients during anesthesia15. Saleem et al. reported 
the hemodynamic stability in ketofol as more than in pro-
pofol and thiopental16. The combination of propofol and 
ketamine has a high degree of hemodynamic stability in 
other studies by Furuya et al., Ghatak et al., Goh et al., 
and Ozgul et al. In this study, despite the fact that there 
was a decrease in blood pressure and heart rate in both 
groups, no hemodynamic instability was reported, and all 
patients had stable hemodynamic parameters9,17,18,19. Like 
the previous studies, the two drugs, ketofol and thiopen-
tal, showed decreased but stable vital signs.
In a study by Ustun et al., the duration of sedation was 
36.2 minutes for ketofol recipients and 24.24 minutes for 
the thiopental sodium patients, which was statistically sig-
nificant13. The duration of hospital stay was 20.4 minutes 
in the ketofol group and 4.9 minutes in the thiopental 
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group, respectively. In a study by Del Pizzo et al., the du-
ration of sedation was 20 minutes in the propofol group 
(propofol + ketamine with separate infusion) and recov-
ery time was 18 minutes. In the ketamine group, it was 
19 minutes (P = 0.469) and the recovery time was 11, 9, 
and 12 minutes (P = 0.704)20. A study by Coulter et al. 
compared proportions of ketamine and propofol in the 
ketofol drug and reported that a ratio of 1 to 3 ketamine 
to propofol was appropriate in short procedures (5 to 20 
minutes), and by administration of this drug can be pre-
vented from multiple injections with a ratio of 1 to 4. But 
the injection of ketofol with a ratio of 1 to 4 can increase 
recovery time to over 20 minutes21. In a study by Frey et 
al., the sedation time in recipients of ketofol and propofol 
was 164 and 235 seconds, respectively. In this study as in 
other studies, the need for re-administration of ketofol 
was less than thiopental. On the other hand, the ketofol 
recipients had a shorter duration of recovery10.
Regarding side effects, Sawas et al. reported that ketofol 
has fewer side effects than propofol, and it is generally 
accepted as a better anesthetic drug8. Gholipur et al. also 
reported that 15% of recipients had muscle contractions, 
and 27.5% had nausea and vomiting while receiving ket-
amine + thiopental (with separate infusion), 20% had 
muscle contractions, and 7.5% had nausea and vomiting 
during surgery, while the patients receiving ketofol did not 
have any side effects14. Jalili et al. reported that ketofol 
had significantly fewer complications than other anes-
thetic drugs, including hallucinations, muscle rigidity, nau-
sea, and vomiting11. A review of other studies has found 
that propofol in patients reduces nausea and vomiting; 
the mechanism of this event is not well understood22, but 
its adjuvant effects or its weak antagonistic effects on the 
subcortical route can be considered23.
he results of this study showed that ketofol is 
a better drug than thiopental for the induction 
of anesthesia, reducing the need for medication, 
the incidence of apnea, and the complications of anesthesia. 
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